Form 8-K - Current report:
SEC Accession No. 0001104659-25-055990
Filing Date
2025-06-03
Accepted
2025-06-03 16:30:39
Documents
12
Period of Report
2025-06-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2517053d1_8k.htm   iXBRL 8-K 63852
  Complete submission text file 0001104659-25-055990.txt   230281

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA knsa-20250603.xsd EX-101.SCH 3011
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE knsa-20250603_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE knsa-20250603_pre.xml EX-101.PRE 22356
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2517053d1_8k_htm.xml XML 3595
Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Filer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38492 | Film No.: 251020091
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)